世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
新生児スクリーニング検査：世界市場シェアとランキング、全体売上高と需要予測 2024-2030Newborn Screening Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030 新生児スクリーニング検査の世界市場は、2023年には6億6,000万米ドルの価値があると推定され、2024年から2030年の予測期間中のCAGRは2.4％で、2030年には7億7,740万米ドルの再調整された規模になると予測されてい... もっと見る
※当ページの内容はウェブ更新時の情報です。 
サマリー新生児スクリーニング検査の世界市場は、2023年には6億6,000万米ドルの価値があると推定され、2024年から2030年の予測期間中のCAGRは2.4％で、2030年には7億7,740万米ドルの再調整された規模になると予測されています。新生児スクリーニング検査の北米市場は、2023年に100万ドルと評価され、2024年から2030年の予測期間中に％CAGRで、2030年までに100万ドルに達する見込みです。 新生児スクリーニング検査のアジア太平洋市場は、2023年に100万ドルと評価され、2024年から2030年の予測期間中に％のCAGRで、2030年までに100万ドルに達するだろう。 新生児スクリーニング検査のヨーロッパ市場は、2023年に100万ドルと評価され、2024年から2030年の予測期間中に％のCAGRで、2030年までに100万ドルに達するでしょう。 新生児スクリーニング検査の世界の主要企業には、AB Sciex LLC、Bio-Rad、Agilent Technologies、Covidien PLC（Medtronic）、GE Healthcare、Thermo Fisher Scientific、Zentech、Trivitron Healthcare、PerkinElmerなどがあります。2023年、世界の大手5社の売上高シェアは約 %である。 レポートの範囲 本レポートは、新生児スクリーニング検査の世界市場を包括的に紹介することを目的としており、地域別・国別、タイプ別、用途別の新生児スクリーニング検査の分析とともに、総売上高、主要企業の市場シェア、ランキングに焦点を当てています。 新生児スクリーニング検査市場規模、推計、予測は、2023年を基準年として、2019年から2030年までの期間の履歴データと予測データを売上高（百万ドル）で提供します。定量分析および定性分析により、読者がビジネス/成長戦略を策定し、市場競争状況を評価し、現在の市場における自社のポジションを分析し、新生児スクリーニング検査に関する情報に基づいたビジネス上の意思決定を行うことを支援します。 市場区分 企業別 AB Sciex LLC バイオ・ラッド アジレント・テクノロジー コヴィディエンPLC（メドトロニック） GEヘルスケア サーモフィッシャーサイエンティフィック ゼンテック トリビトロンヘルスケア パーキンエルマー ナトゥスメディカル MPバイオメディカル アポロクレードル ライフセル ベイビージーンズ タイプ別セグメント 聴覚スクリーニング検査 重症先天性心疾患検査（CCHD検査） 乾燥血液スポット検査 その他 用途別セグメント 病院 診療所 診断センター その他 地域別 北米 米国 カナダ 欧州 ドイツ フランス 英国 イタリア ロシア アジア太平洋 中国 日本 韓国 中国 台湾 東南アジア インド ラテンアメリカ メキシコ ブラジル アルゼンチン 中東・アフリカ トルコ サウジアラビア アラブ首長国連邦 各章の概要 第1章：報告書のスコープ、世界の総市場規模を紹介。本章ではまた、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界のメーカーが直面する課題とリスク、業界の関連政策の分析を提供します。 第2章：新生児スクリーニング検査メーカーの競争環境、収益市場シェア、最新の開発計画、合併・買収情報などを詳細に分析します。 第3章：各種市場セグメントをタイプ別に分析し、各市場セグメントの市場規模や発展可能性を網羅し、読者が各市場セグメントにおけるブルーオーシャン市場を見つけやすくします。 第4章：用途別の様々な市場セグメントの分析を提供し、各市場セグメントの市場規模と発展可能性をカバーし、読者が異なる下流市場のブルーオーシャン市場を見つけるのを助ける。 第5章：地域レベルでの新生児スクリーニング検査の収益。各地域の市場規模と発展可能性を定量的に分析し、世界各国の市場発展、今後の発展見通し、市場スペース、市場規模を紹介しています。 第6章 新生児スクリーニング検査の国別収益各国・地域のタイプ別、用途別のシグメイトデータを提供しています。 第7章：主要企業のプロフィールを提供し、製品収益、粗利益率、製品紹介、最近の開発など、市場における主要企業の基本的な状況を詳細に紹介する。 第8章：産業の上流と下流を含む産業チェーンの分析。 第9章：結論 目次1 Market Overview1.1 Newborn Screening Testing Product Introduction 1.2 Global Newborn Screening Testing Market Size Forecast 1.3 Newborn Screening Testing Market Trends & Drivers 1.3.1 Newborn Screening Testing Industry Trends 1.3.2 Newborn Screening Testing Market Drivers & Opportunity 1.3.3 Newborn Screening Testing Market Challenges 1.3.4 Newborn Screening Testing Market Restraints 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Competitive Analysis by Company 2.1 Global Newborn Screening Testing Players Revenue Ranking (2023) 2.2 Global Newborn Screening Testing Revenue by Company (2019-2024) 2.3 Key Companies Newborn Screening Testing Manufacturing Base Distribution and Headquarters 2.4 Key Companies Newborn Screening Testing Product Offered 2.5 Key Companies Time to Begin Mass Production of Newborn Screening Testing 2.6 Newborn Screening Testing Market Competitive Analysis 2.6.1 Newborn Screening Testing Market Concentration Rate (2019-2024) 2.6.2 Global 5 and 10 Largest Companies by Newborn Screening Testing Revenue in 2023 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Newborn Screening Testing as of 2023) 2.7 Mergers & Acquisitions, Expansion 3 Segmentation by Type 3.1 Introduction by Type 3.1.1 Hearing Screening Test 3.1.2 Critical Congenital Heart Disease Test (CCHD Test) 3.1.3 Dry Blood Spot Test 3.1.4 Others 3.2 Global Newborn Screening Testing Sales Value by Type 3.2.1 Global Newborn Screening Testing Sales Value by Type (2019 VS 2023 VS 2030) 3.2.2 Global Newborn Screening Testing Sales Value, by Type (2019-2030) 3.2.3 Global Newborn Screening Testing Sales Value, by Type (%) (2019-2030) 4 Segmentation by Application 4.1 Introduction by Application 4.1.1 Hospitals 4.1.2 Clinics 4.1.3 Diagnostic Centers 4.1.4 Others 4.2 Global Newborn Screening Testing Sales Value by Application 4.2.1 Global Newborn Screening Testing Sales Value by Application (2019 VS 2023 VS 2030) 4.2.2 Global Newborn Screening Testing Sales Value, by Application (2019-2030) 4.2.3 Global Newborn Screening Testing Sales Value, by Application (%) (2019-2030) 5 Segmentation by Region 5.1 Global Newborn Screening Testing Sales Value by Region 5.1.1 Global Newborn Screening Testing Sales Value by Region: 2019 VS 2023 VS 2030 5.1.2 Global Newborn Screening Testing Sales Value by Region (2019-2024) 5.1.3 Global Newborn Screening Testing Sales Value by Region (2025-2030) 5.1.4 Global Newborn Screening Testing Sales Value by Region (%), (2019-2030) 5.2 North America 5.2.1 North America Newborn Screening Testing Sales Value, 2019-2030 5.2.2 North America Newborn Screening Testing Sales Value by Country (%), 2023 VS 2030 5.3 Europe 5.3.1 Europe Newborn Screening Testing Sales Value, 2019-2030 5.3.2 Europe Newborn Screening Testing Sales Value by Country (%), 2023 VS 2030 5.4 Asia Pacific 5.4.1 Asia Pacific Newborn Screening Testing Sales Value, 2019-2030 5.4.2 Asia Pacific Newborn Screening Testing Sales Value by Country (%), 2023 VS 2030 5.5 South America 5.5.1 South America Newborn Screening Testing Sales Value, 2019-2030 5.5.2 South America Newborn Screening Testing Sales Value by Country (%), 2023 VS 2030 5.6 Middle East & Africa 5.6.1 Middle East & Africa Newborn Screening Testing Sales Value, 2019-2030 5.6.2 Middle East & Africa Newborn Screening Testing Sales Value by Country (%), 2023 VS 2030 6 Segmentation by Key Countries/Regions 6.1 Key Countries/Regions Newborn Screening Testing Sales Value Growth Trends, 2019 VS 2023 VS 2030 6.2 Key Countries/Regions Newborn Screening Testing Sales Value 6.3 United States 6.3.1 United States Newborn Screening Testing Sales Value, 2019-2030 6.3.2 United States Newborn Screening Testing Sales Value by Type (%), 2023 VS 2030 6.3.3 United States Newborn Screening Testing Sales Value by Application, 2023 VS 2030 6.4 Europe 6.4.1 Europe Newborn Screening Testing Sales Value, 2019-2030 6.4.2 Europe Newborn Screening Testing Sales Value by Type (%), 2023 VS 2030 6.4.3 Europe Newborn Screening Testing Sales Value by Application, 2023 VS 2030 6.5 China 6.5.1 China Newborn Screening Testing Sales Value, 2019-2030 6.5.2 China Newborn Screening Testing Sales Value by Type (%), 2023 VS 2030 6.5.3 China Newborn Screening Testing Sales Value by Application, 2023 VS 2030 6.6 Japan 6.6.1 Japan Newborn Screening Testing Sales Value, 2019-2030 6.6.2 Japan Newborn Screening Testing Sales Value by Type (%), 2023 VS 2030 6.6.3 Japan Newborn Screening Testing Sales Value by Application, 2023 VS 2030 6.7 South Korea 6.7.1 South Korea Newborn Screening Testing Sales Value, 2019-2030 6.7.2 South Korea Newborn Screening Testing Sales Value by Type (%), 2023 VS 2030 6.7.3 South Korea Newborn Screening Testing Sales Value by Application, 2023 VS 2030 6.8 Southeast Asia 6.8.1 Southeast Asia Newborn Screening Testing Sales Value, 2019-2030 6.8.2 Southeast Asia Newborn Screening Testing Sales Value by Type (%), 2023 VS 2030 6.8.3 Southeast Asia Newborn Screening Testing Sales Value by Application, 2023 VS 2030 6.9 India 6.9.1 India Newborn Screening Testing Sales Value, 2019-2030 6.9.2 India Newborn Screening Testing Sales Value by Type (%), 2023 VS 2030 6.9.3 India Newborn Screening Testing Sales Value by Application, 2023 VS 2030 7 Company Profiles 7.1 AB Sciex LLC 7.1.1 AB Sciex LLC Profile 7.1.2 AB Sciex LLC Main Business 7.1.3 AB Sciex LLC Newborn Screening Testing Products, Services and Solutions 7.1.4 AB Sciex LLC Newborn Screening Testing Revenue (US$ Million) & (2019-2024) 7.1.5 AB Sciex LLC Recent Developments 7.2 Bio-Rad 7.2.1 Bio-Rad Profile 7.2.2 Bio-Rad Main Business 7.2.3 Bio-Rad Newborn Screening Testing Products, Services and Solutions 7.2.4 Bio-Rad Newborn Screening Testing Revenue (US$ Million) & (2019-2024) 7.2.5 Bio-Rad Recent Developments 7.3 Agilent Technologies 7.3.1 Agilent Technologies Profile 7.3.2 Agilent Technologies Main Business 7.3.3 Agilent Technologies Newborn Screening Testing Products, Services and Solutions 7.3.4 Agilent Technologies Newborn Screening Testing Revenue (US$ Million) & (2019-2024) 7.3.5 Covidien PLC (Medtronic) Recent Developments 7.4 Covidien PLC (Medtronic) 7.4.1 Covidien PLC (Medtronic) Profile 7.4.2 Covidien PLC (Medtronic) Main Business 7.4.3 Covidien PLC (Medtronic) Newborn Screening Testing Products, Services and Solutions 7.4.4 Covidien PLC (Medtronic) Newborn Screening Testing Revenue (US$ Million) & (2019-2024) 7.4.5 Covidien PLC (Medtronic) Recent Developments 7.5 GE Healthcare 7.5.1 GE Healthcare Profile 7.5.2 GE Healthcare Main Business 7.5.3 GE Healthcare Newborn Screening Testing Products, Services and Solutions 7.5.4 GE Healthcare Newborn Screening Testing Revenue (US$ Million) & (2019-2024) 7.5.5 GE Healthcare Recent Developments 7.6 Thermo Fisher Scientific 7.6.1 Thermo Fisher Scientific Profile 7.6.2 Thermo Fisher Scientific Main Business 7.6.3 Thermo Fisher Scientific Newborn Screening Testing Products, Services and Solutions 7.6.4 Thermo Fisher Scientific Newborn Screening Testing Revenue (US$ Million) & (2019-2024) 7.6.5 Thermo Fisher Scientific Recent Developments 7.7 Zentech 7.7.1 Zentech Profile 7.7.2 Zentech Main Business 7.7.3 Zentech Newborn Screening Testing Products, Services and Solutions 7.7.4 Zentech Newborn Screening Testing Revenue (US$ Million) & (2019-2024) 7.7.5 Zentech Recent Developments 7.8 Trivitron Healthcare 7.8.1 Trivitron Healthcare Profile 7.8.2 Trivitron Healthcare Main Business 7.8.3 Trivitron Healthcare Newborn Screening Testing Products, Services and Solutions 7.8.4 Trivitron Healthcare Newborn Screening Testing Revenue (US$ Million) & (2019-2024) 7.8.5 Trivitron Healthcare Recent Developments 7.9 PerkinElmer 7.9.1 PerkinElmer Profile 7.9.2 PerkinElmer Main Business 7.9.3 PerkinElmer Newborn Screening Testing Products, Services and Solutions 7.9.4 PerkinElmer Newborn Screening Testing Revenue (US$ Million) & (2019-2024) 7.9.5 PerkinElmer Recent Developments 7.10 Natus Medical 7.10.1 Natus Medical Profile 7.10.2 Natus Medical Main Business 7.10.3 Natus Medical Newborn Screening Testing Products, Services and Solutions 7.10.4 Natus Medical Newborn Screening Testing Revenue (US$ Million) & (2019-2024) 7.10.5 Natus Medical Recent Developments 7.11 MP Biomedicals 7.11.1 MP Biomedicals Profile 7.11.2 MP Biomedicals Main Business 7.11.3 MP Biomedicals Newborn Screening Testing Products, Services and Solutions 7.11.4 MP Biomedicals Newborn Screening Testing Revenue (US$ Million) & (2019-2024) 7.11.5 MP Biomedicals Recent Developments 7.12 Apollo Cradle 7.12.1 Apollo Cradle Profile 7.12.2 Apollo Cradle Main Business 7.12.3 Apollo Cradle Newborn Screening Testing Products, Services and Solutions 7.12.4 Apollo Cradle Newborn Screening Testing Revenue (US$ Million) & (2019-2024) 7.12.5 Apollo Cradle Recent Developments 7.13 LifeCell 7.13.1 LifeCell Profile 7.13.2 LifeCell Main Business 7.13.3 LifeCell Newborn Screening Testing Products, Services and Solutions 7.13.4 LifeCell Newborn Screening Testing Revenue (US$ Million) & (2019-2024) 7.13.5 LifeCell Recent Developments 7.14 Baby Genes 7.14.1 Baby Genes Profile 7.14.2 Baby Genes Main Business 7.14.3 Baby Genes Newborn Screening Testing Products, Services and Solutions 7.14.4 Baby Genes Newborn Screening Testing Revenue (US$ Million) & (2019-2024) 7.14.5 Baby Genes Recent Developments 8 Industry Chain Analysis 8.1 Newborn Screening Testing Industrial Chain 8.2 Newborn Screening Testing Upstream Analysis 8.2.1 Key Raw Materials 8.2.2 Raw Materials Key Suppliers 8.2.3 Manufacturing Cost Structure 8.3 Midstream Analysis 8.4 Downstream Analysis (Customers Analysis) 8.5 Sales Model and Sales Channels 8.5.1 Newborn Screening Testing Sales Model 8.5.2 Sales Channel 8.5.3 Newborn Screening Testing Distributors 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.2 Data Source 10.2 Author Details 10.3 Disclaimer
SummaryThe global market for Newborn Screening Testing was estimated to be worth US$ 660 million in 2023 and is forecast to a readjusted size of US$ 777.4 million by 2030 with a CAGR of 2.4% during the forecast period 2024-2030 Table of Contents1 Market Overview1.1 Newborn Screening Testing Product Introduction 1.2 Global Newborn Screening Testing Market Size Forecast 1.3 Newborn Screening Testing Market Trends & Drivers 1.3.1 Newborn Screening Testing Industry Trends 1.3.2 Newborn Screening Testing Market Drivers & Opportunity 1.3.3 Newborn Screening Testing Market Challenges 1.3.4 Newborn Screening Testing Market Restraints 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Competitive Analysis by Company 2.1 Global Newborn Screening Testing Players Revenue Ranking (2023) 2.2 Global Newborn Screening Testing Revenue by Company (2019-2024) 2.3 Key Companies Newborn Screening Testing Manufacturing Base Distribution and Headquarters 2.4 Key Companies Newborn Screening Testing Product Offered 2.5 Key Companies Time to Begin Mass Production of Newborn Screening Testing 2.6 Newborn Screening Testing Market Competitive Analysis 2.6.1 Newborn Screening Testing Market Concentration Rate (2019-2024) 2.6.2 Global 5 and 10 Largest Companies by Newborn Screening Testing Revenue in 2023 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Newborn Screening Testing as of 2023) 2.7 Mergers & Acquisitions, Expansion 3 Segmentation by Type 3.1 Introduction by Type 3.1.1 Hearing Screening Test 3.1.2 Critical Congenital Heart Disease Test (CCHD Test) 3.1.3 Dry Blood Spot Test 3.1.4 Others 3.2 Global Newborn Screening Testing Sales Value by Type 3.2.1 Global Newborn Screening Testing Sales Value by Type (2019 VS 2023 VS 2030) 3.2.2 Global Newborn Screening Testing Sales Value, by Type (2019-2030) 3.2.3 Global Newborn Screening Testing Sales Value, by Type (%) (2019-2030) 4 Segmentation by Application 4.1 Introduction by Application 4.1.1 Hospitals 4.1.2 Clinics 4.1.3 Diagnostic Centers 4.1.4 Others 4.2 Global Newborn Screening Testing Sales Value by Application 4.2.1 Global Newborn Screening Testing Sales Value by Application (2019 VS 2023 VS 2030) 4.2.2 Global Newborn Screening Testing Sales Value, by Application (2019-2030) 4.2.3 Global Newborn Screening Testing Sales Value, by Application (%) (2019-2030) 5 Segmentation by Region 5.1 Global Newborn Screening Testing Sales Value by Region 5.1.1 Global Newborn Screening Testing Sales Value by Region: 2019 VS 2023 VS 2030 5.1.2 Global Newborn Screening Testing Sales Value by Region (2019-2024) 5.1.3 Global Newborn Screening Testing Sales Value by Region (2025-2030) 5.1.4 Global Newborn Screening Testing Sales Value by Region (%), (2019-2030) 5.2 North America 5.2.1 North America Newborn Screening Testing Sales Value, 2019-2030 5.2.2 North America Newborn Screening Testing Sales Value by Country (%), 2023 VS 2030 5.3 Europe 5.3.1 Europe Newborn Screening Testing Sales Value, 2019-2030 5.3.2 Europe Newborn Screening Testing Sales Value by Country (%), 2023 VS 2030 5.4 Asia Pacific 5.4.1 Asia Pacific Newborn Screening Testing Sales Value, 2019-2030 5.4.2 Asia Pacific Newborn Screening Testing Sales Value by Country (%), 2023 VS 2030 5.5 South America 5.5.1 South America Newborn Screening Testing Sales Value, 2019-2030 5.5.2 South America Newborn Screening Testing Sales Value by Country (%), 2023 VS 2030 5.6 Middle East & Africa 5.6.1 Middle East & Africa Newborn Screening Testing Sales Value, 2019-2030 5.6.2 Middle East & Africa Newborn Screening Testing Sales Value by Country (%), 2023 VS 2030 6 Segmentation by Key Countries/Regions 6.1 Key Countries/Regions Newborn Screening Testing Sales Value Growth Trends, 2019 VS 2023 VS 2030 6.2 Key Countries/Regions Newborn Screening Testing Sales Value 6.3 United States 6.3.1 United States Newborn Screening Testing Sales Value, 2019-2030 6.3.2 United States Newborn Screening Testing Sales Value by Type (%), 2023 VS 2030 6.3.3 United States Newborn Screening Testing Sales Value by Application, 2023 VS 2030 6.4 Europe 6.4.1 Europe Newborn Screening Testing Sales Value, 2019-2030 6.4.2 Europe Newborn Screening Testing Sales Value by Type (%), 2023 VS 2030 6.4.3 Europe Newborn Screening Testing Sales Value by Application, 2023 VS 2030 6.5 China 6.5.1 China Newborn Screening Testing Sales Value, 2019-2030 6.5.2 China Newborn Screening Testing Sales Value by Type (%), 2023 VS 2030 6.5.3 China Newborn Screening Testing Sales Value by Application, 2023 VS 2030 6.6 Japan 6.6.1 Japan Newborn Screening Testing Sales Value, 2019-2030 6.6.2 Japan Newborn Screening Testing Sales Value by Type (%), 2023 VS 2030 6.6.3 Japan Newborn Screening Testing Sales Value by Application, 2023 VS 2030 6.7 South Korea 6.7.1 South Korea Newborn Screening Testing Sales Value, 2019-2030 6.7.2 South Korea Newborn Screening Testing Sales Value by Type (%), 2023 VS 2030 6.7.3 South Korea Newborn Screening Testing Sales Value by Application, 2023 VS 2030 6.8 Southeast Asia 6.8.1 Southeast Asia Newborn Screening Testing Sales Value, 2019-2030 6.8.2 Southeast Asia Newborn Screening Testing Sales Value by Type (%), 2023 VS 2030 6.8.3 Southeast Asia Newborn Screening Testing Sales Value by Application, 2023 VS 2030 6.9 India 6.9.1 India Newborn Screening Testing Sales Value, 2019-2030 6.9.2 India Newborn Screening Testing Sales Value by Type (%), 2023 VS 2030 6.9.3 India Newborn Screening Testing Sales Value by Application, 2023 VS 2030 7 Company Profiles 7.1 AB Sciex LLC 7.1.1 AB Sciex LLC Profile 7.1.2 AB Sciex LLC Main Business 7.1.3 AB Sciex LLC Newborn Screening Testing Products, Services and Solutions 7.1.4 AB Sciex LLC Newborn Screening Testing Revenue (US$ Million) & (2019-2024) 7.1.5 AB Sciex LLC Recent Developments 7.2 Bio-Rad 7.2.1 Bio-Rad Profile 7.2.2 Bio-Rad Main Business 7.2.3 Bio-Rad Newborn Screening Testing Products, Services and Solutions 7.2.4 Bio-Rad Newborn Screening Testing Revenue (US$ Million) & (2019-2024) 7.2.5 Bio-Rad Recent Developments 7.3 Agilent Technologies 7.3.1 Agilent Technologies Profile 7.3.2 Agilent Technologies Main Business 7.3.3 Agilent Technologies Newborn Screening Testing Products, Services and Solutions 7.3.4 Agilent Technologies Newborn Screening Testing Revenue (US$ Million) & (2019-2024) 7.3.5 Covidien PLC (Medtronic) Recent Developments 7.4 Covidien PLC (Medtronic) 7.4.1 Covidien PLC (Medtronic) Profile 7.4.2 Covidien PLC (Medtronic) Main Business 7.4.3 Covidien PLC (Medtronic) Newborn Screening Testing Products, Services and Solutions 7.4.4 Covidien PLC (Medtronic) Newborn Screening Testing Revenue (US$ Million) & (2019-2024) 7.4.5 Covidien PLC (Medtronic) Recent Developments 7.5 GE Healthcare 7.5.1 GE Healthcare Profile 7.5.2 GE Healthcare Main Business 7.5.3 GE Healthcare Newborn Screening Testing Products, Services and Solutions 7.5.4 GE Healthcare Newborn Screening Testing Revenue (US$ Million) & (2019-2024) 7.5.5 GE Healthcare Recent Developments 7.6 Thermo Fisher Scientific 7.6.1 Thermo Fisher Scientific Profile 7.6.2 Thermo Fisher Scientific Main Business 7.6.3 Thermo Fisher Scientific Newborn Screening Testing Products, Services and Solutions 7.6.4 Thermo Fisher Scientific Newborn Screening Testing Revenue (US$ Million) & (2019-2024) 7.6.5 Thermo Fisher Scientific Recent Developments 7.7 Zentech 7.7.1 Zentech Profile 7.7.2 Zentech Main Business 7.7.3 Zentech Newborn Screening Testing Products, Services and Solutions 7.7.4 Zentech Newborn Screening Testing Revenue (US$ Million) & (2019-2024) 7.7.5 Zentech Recent Developments 7.8 Trivitron Healthcare 7.8.1 Trivitron Healthcare Profile 7.8.2 Trivitron Healthcare Main Business 7.8.3 Trivitron Healthcare Newborn Screening Testing Products, Services and Solutions 7.8.4 Trivitron Healthcare Newborn Screening Testing Revenue (US$ Million) & (2019-2024) 7.8.5 Trivitron Healthcare Recent Developments 7.9 PerkinElmer 7.9.1 PerkinElmer Profile 7.9.2 PerkinElmer Main Business 7.9.3 PerkinElmer Newborn Screening Testing Products, Services and Solutions 7.9.4 PerkinElmer Newborn Screening Testing Revenue (US$ Million) & (2019-2024) 7.9.5 PerkinElmer Recent Developments 7.10 Natus Medical 7.10.1 Natus Medical Profile 7.10.2 Natus Medical Main Business 7.10.3 Natus Medical Newborn Screening Testing Products, Services and Solutions 7.10.4 Natus Medical Newborn Screening Testing Revenue (US$ Million) & (2019-2024) 7.10.5 Natus Medical Recent Developments 7.11 MP Biomedicals 7.11.1 MP Biomedicals Profile 7.11.2 MP Biomedicals Main Business 7.11.3 MP Biomedicals Newborn Screening Testing Products, Services and Solutions 7.11.4 MP Biomedicals Newborn Screening Testing Revenue (US$ Million) & (2019-2024) 7.11.5 MP Biomedicals Recent Developments 7.12 Apollo Cradle 7.12.1 Apollo Cradle Profile 7.12.2 Apollo Cradle Main Business 7.12.3 Apollo Cradle Newborn Screening Testing Products, Services and Solutions 7.12.4 Apollo Cradle Newborn Screening Testing Revenue (US$ Million) & (2019-2024) 7.12.5 Apollo Cradle Recent Developments 7.13 LifeCell 7.13.1 LifeCell Profile 7.13.2 LifeCell Main Business 7.13.3 LifeCell Newborn Screening Testing Products, Services and Solutions 7.13.4 LifeCell Newborn Screening Testing Revenue (US$ Million) & (2019-2024) 7.13.5 LifeCell Recent Developments 7.14 Baby Genes 7.14.1 Baby Genes Profile 7.14.2 Baby Genes Main Business 7.14.3 Baby Genes Newborn Screening Testing Products, Services and Solutions 7.14.4 Baby Genes Newborn Screening Testing Revenue (US$ Million) & (2019-2024) 7.14.5 Baby Genes Recent Developments 8 Industry Chain Analysis 8.1 Newborn Screening Testing Industrial Chain 8.2 Newborn Screening Testing Upstream Analysis 8.2.1 Key Raw Materials 8.2.2 Raw Materials Key Suppliers 8.2.3 Manufacturing Cost Structure 8.3 Midstream Analysis 8.4 Downstream Analysis (Customers Analysis) 8.5 Sales Model and Sales Channels 8.5.1 Newborn Screening Testing Sales Model 8.5.2 Sales Channel 8.5.3 Newborn Screening Testing Distributors 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.2 Data Source 10.2 Author Details 10.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療）の最新刊レポートQYResearch社の医療分野での最新刊レポート
本レポートと同じKEY WORD（demand forecast）の最新刊レポートよくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/18 10:26 155.35 円 164.28 円 199.02 円 |
